USPTO serial 79185261
BE THE PARTNER
Reviewed by CopyMark Law Group
Reg. 5043445Status 404
- Filing date
- Status date
- Registration date
- Sep 20, 2016
- Examiner
- STINSON, JENNIFER ELLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BE THE PARTNER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ursula B. Day
Ursula B. Day Law firm of Ursula B. Day708 third ave1501new york, NY 10017Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Data processing equipment, namely, scanners; blank magnetic data carriers; blank optical data carriers; recorded computer operating programs and computer software for medical data processing; downloadable computer programs for use in medical database management; computer software for image processing, for document management, for printer management, for network transmission and reception, for document creation, for creating, updating and maintenance of websites, for generating and automatic sending of electronic messages, for database management and for document and image processing in relation to medical, biological and patient-related data, including data from and for clinical studies; Software for providing electronic databases containing information regarding electronic commerce, business processes, and software solutions; computer programs for capturing specific customer marketing | SECTION 71 - CANCELLED | — |
| 035 | Collection of information into computer databases, namely, collating data in relation to clinical studies; compilation and systemization of information, namely, data in relation to clinical studies into computer databases; online e-commerce provider services, namely, presentation of goods and services on communication media for advertising purpose for others, order placement and order delivery services in the nature of electronic processing of orders and invoice management, including within the framework of e-commerce, in the field of trading in biological material; procuring of contracts, for others, for the buying and selling of goods and for the use of services in connection with trading in biological material and medical goods and preparations; organization of exhibitions for commercial or advertising purposes; arranging of trading transactions and economic contracts via the Internet; procuring of contracts, for others, for the buying and selling of goods and for the use of services in relation to trading in biological material and medical goods and preparations; services of advertising agencies; advertising services, namely, presentation of companies on the internet and other media; business management, business management consulting; business management and organization consultancy; business administration services; business consultancy and advisory services in the field of digital health management; personnel management consultancy; organizational project management services for others in the field of electronic data processing; professional business consultancy for franchise concepts; business management and organization consultancy, including relating to creating business plans for others, providing business and marketing information | SECTION 71 - CANCELLED | — |
| 038 | Providing Internet access to platforms and portals; providing Internet access to portals; providing Internet access to an e-commerce platform in relation to trading in biological material and medical goods and preparations; transmission of information in relation to pharmacies, medicine and hygiene, and results from clinical studies; electronic exchange of data stored in databases accessible via telecommunication networks, namely between the pharmaceutical industry, patients and medical clinics in relation to data for clinical studies; providing Internet access by means of access to software on data networks; telecommunication services, namely, presenting and communicating of information stored on databases, in particular including by means of interactive computer systems; providing on-line chat rooms for social networking; providing chat lines, chat rooms, and internet forums for the electronic exchange of messages among computer users concerning exchange of medical information; telecommunication access services by means of platforms and portals on the Internet; rental of access time to a computer database; providing Internet access via access to software on data networks; web messaging; Telecommunication services, namely, electronic bulletin board services; providing Internet access for access to e-commerce platforms; telecommunication services namely online message sending services and transmission of information on computer networks, including on-demand and other electronic media services; electronic data transmission, namely electronic transmission of news and general news information; broadcasting of radio and television programs over the Internet; Radio and television broadcasting services; News agencies, namely, the transmission of news items to news reporting organizations | SECTION 71 - CANCELLED | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; conducting clinical trials for others; consulting services in the field of pharmaceutical research for the pharmaceutical industry, patients and medical clinics in relation to conducting of clinical studies; design and development of computer hardware and computer software; computer programming, namely, in the field of medical research and administration; medical and scientific research, namely, conducting clinical trials for others, and database development services and updating of databases containing biological materials; providing a web hosting platform for e-commerce on the Internet in connection with trading in biological material; web hosting services, namely, providing web space in the nature of facilities for others for conducting interactive discussions and sharing on-line content; providing electronic data storage on the Internet; scientific research conducted using databases and the Internet; providing search engines for the Internet; medical research, namely, laboratory services, namely, medical analysis of biological material, namely, blood, plasma, biological cells, biological research; conducting clinical trials for others and medical research | SECTION 71 - CANCELLED | — |
| 044 | Blood banks, transplant banks, in particular containing biological material, antibodies, blood, artificial blood, plasma, bone marrow, biological tissue, biological cells, stem cells, t-cells; medical services; Physical examination services, namely medical and clinical examinations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cytolon Digital Health AG
- Other trademarks owned by Cytolon Digital Health AG
- Other trademarks owned by Cytolon Digital Health AG
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BE THE PARTNER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 16, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 7, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 20, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 20, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 30, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 31, 2023 | C71T | CANCELLED SECTION 71 | — |
| Sep 20, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 9, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 6, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 21, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 21, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 20, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 20, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 15, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 15, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 1, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 23, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 23, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 23, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 3, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 3, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 3, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 16, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 28, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |